| Cesamet (nabilone) / Bausch Health, Viatris |
| Recruiting | 4 | 30 | Canada | Nabilone Oral Capsule, TEVA-nabilone | Centre for Addiction and Mental Health | Healthy | 10/26 | 10/26 | | |
2009-011862-27: Überprufung der wirksamkeit und Sicherheit einer Add-on Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit Tumorschmerz |
|
|
| Ongoing | 3 | 40 | Europe | Nabilone 0,5 mg, | ZISOP Zentrum für interdisziplinäre Schmerztherapie Landeskrankenhaus Klagenfurt | Pain related to cancer (solid tumors) | | | | |
2017-004253-16: Investigation of the effect of Nabilon in patients suffering from Parkinson´s Disease with non-Motor symptoms (e.g.sleeping dirsorders, cognitive dysfunction, hallucinations, autonomic dysfunction,...) |
|
|
| Ongoing | 3 | 48 | Europe | Nabilone, Capsule, hard | Medizinische Universität Innsbruck, Universitätsklinik für Neurologie, AOP Orphan Pharmaceuticals AG | Subject with non-Motor symptoms of Parkinson´s disease, Parkinson´s disease, Diseases [C] - Nervous System Diseases [C10] | | | | |
| Completed | 3 | 14 | Canada | Nabilone 0.5 MG Oral Capsule, TEVA-Nabilone, Placebo Nabilone, TEVA-Nabilone Placebo | University of Manitoba, Population Health Research Institute | End Stage Renal Disease, Pruritus | 08/23 | 08/23 | | |
| Recruiting | 3 | 112 | Canada | Nabilone, Cesamet, Placebo | Sunnybrook Health Sciences Centre, Alzheimer's Drug Discovery Foundation, Weston Brain Institute | Alzheimer Disease, Agitation | 10/25 | 10/25 | | |
CATNP, NCT04057456: Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury |
|
|
| Recruiting | 3 | 140 | Canada | Placebo diet, Anti-inflammatory diet, Nabilone Capsules, Placebo capsules | Eldon Loh, MD, Ontario Neurotrauma Foundation | Spinal Cord Injuries, Neuropathic Pain | 06/26 | 12/26 | | |
2015-004227-31: Clinical pilot study to review the impact of perioperative administration of the synthetic cannabinoid nabilone in the context of spinal fusion surgery on the coping with surgery and the pain perception of patients with severely reduced quality of life Klinische Pilotstudie zur Überprüfung des Einflusses einer perioperativen Einnahme des synthetischen Cannabinoids Nabilon im Rahmen stabilisierender Wirbelsäulenoperationen auf die Operationsbewältigung und das Schmerzempfinden von Patienten mit stark reduzierter Lebensqualität |
|
|
| Ongoing | 2 | 36 | Europe | Capsule, Canemes 1 mg Kapseln | OA Dr. Philipp Becker c/o Abteilung für Wirbelsäulenchirurgie, Orthopädisches Spital Speising GmbH, Orthopädisches Spital Speising GmbH, AOP Orphan Pharmaceuticals AG | Spine disease Wirbelsäulenerkrankung, Spine disease Wirbelsäulenerkrankung, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
2017-000192-86: Investigation of the effect of Nabilon in patients suffering from Parkinson´s Disease with non-motor symptoms (e.g.sleeping disorders,cognitive dysfunction, hallucinations, autonomic dysfunction including urinary incontinence, constipation,...) |
|
|
| Ongoing | 2 | 48 | Europe | Nabilone, Capsule | Medizinische Universität Innsbruck, Universitätsklinik für Neurologie, AOP Orphan Pharmaceuticals AG | Subjects with non-motor symptoms of Parkinson´s disease, Parkinson´s disease, Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT04801641: A Pilot Trial of Nabilone for the Treatment of Obesity |
|
|
| Terminated | 2 | 24 | Canada | Placebo, Nabilone | Centre for Addiction and Mental Health | Obesity | 08/23 | 08/23 | | |
NCT05494437: Effect of PP-01 on Cannabis Withdrawal Syndrome |
|
|
| Completed | 2 | 234 | US | PP-01 High Dose, PP-01 Low Dose, Placebo, Nabilone, Gabapentin | PleoPharma, Inc. | Cannabis Withdrawal | 08/23 | 08/23 | | |
| Active, not recruiting | 2 | 45 | Canada | Nabilone, Nabilone Oral Capsule, TEVA Nabilone, Placebo | Simon Ducharme, MD, Alzheimer's Drug Discovery Foundation | Frontotemporal Dementia, Frontotemporal Dementia, Behavioral Variant, Primary Progressive Aphasia, bvFTD, PPA, FTD | 05/25 | 12/25 | | |
NCT04880278: Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder |
|
|
| Withdrawn | 1/2 | 60 | US | Nabilone, Cesamet (brand name), Placebo | New York State Psychiatric Institute, National Institute of Mental Health (NIMH) | Obsessive-Compulsive Disorder | 05/24 | 05/24 | | |
N-AND, NCT05273320: Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities |
|
|
| Recruiting | 1 | 30 | Canada | Nabilone, 02392925 Teva-Nabilone 0.25 mg Capsule; 02384892 Teva-Nabilone 1 mg Capsule | Hsiang-Yuan Lin | Intellectual Disability, Developmental Disability, Aggression, Behavior Problem | 03/24 | 03/24 | | |
NCT03422861: Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients |
|
|
| Not yet recruiting | N/A | 80 | Canada | Nabilone, Cesamet, Placebos | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Inflammatory Bowel Diseases | 09/24 | 12/24 | | |
| Recruiting | N/A | 66 | | | University of Western Australia, University of Western Australia | Psychosis, Schizophrenia | | | | |